Abstract
Upon intravenous injection of tumour necrosis factor (TNF) in mice, a systemic inflammatory response syndrome (SIRS) is initiated, characterized by an acute cytokine storm and induction of vascular hyperpermeability. Connexin43 hemichannels have been implicated in various pathological conditions, e.g. ischemia and inflammation, and can lead to detrimental cellular outcomes. Here, we explored whether targeting connexin43 hemichannels could alleviate TNF-induced endothelial barrier dysfunction and lethality in SIRS. Therefore, we verified whether administration of connexin43-targeting-peptides affected survival, body temperature and vascular permeability in vivo. In vitro, TNF-effects on connexin43 hemichannel function were investigated by single-channel studies and Ca2+-imaging. Blocking connexin43 hemichannels with TAT-Gap19 protected mice against TNF-induced mortality, hypothermia and vascular leakage, while enhancing connexin43 hemichannel function with TAT-CT9 provoked opposite sensitizing effects. In vitro patch-clamp studies revealed that TNF acutely activated connexin43 hemichannel opening in endothelial cells, which was promoted by CT9, and inhibited by Gap19 and intracellular Ca2+-buffering. In vivo experiments aimed at buffering intracellular Ca2+, and pharmacologically targeting Ca2+/calmodulin-dependent protein kinase-II, a known modulator of endothelial barrier integrity, demonstrated their involvement in permeability alterations. Our results demonstrate significant benefits of inhibiting connexin43 hemichannels to counteract TNF-induced SIRS-associated vascular permeability and lethality.
Similar content being viewed by others
Introduction
During TNF-induced SIRS, an exaggerated production and secretion of pro-inflammatory cytokines (e.g. interleukin 6 (IL-6), IL-1) and chemokines (CXCL-1) into the circulation results in the activation and increased permeability of the endothelium1,2,3,4. Endothelial cells (ECs) are connected by different junctional proteins that mediate vascular barrier function and intercellular communication5. The reorganization of tight and adherens junctions has been frequently linked to microvascular dysfunction and hyperpermeability, often induced by TNF and other inflammatory mediators6,7,8. However, little is known on the role of connexins (Cxs) and their channels, i.e. gap junction channels (GJCs) and hemichannels, in the pathogenesis of SIRS. GJCs consist of two hemichannels, each containing 6 Cx proteins. The latter are composed of four transmembrane regions, two extracellular loops, a cytoplasmic loop and cytosolic N- and C-terminal tails. Hemichannels provide a passageway between the intra- and extracellular environment, while GJCs connect the cytoplasm of two neighbouring cells, providing a route for direct cell-cell communication. Both hemichannels and GJCs allow the passage of ions and small molecules (≤1.5 kDa) such as adenosine trisphosphate (ATP) and inositol trisphosphate (IP3)9,10. Cx43 is the most abundant and widespread Cx in mammals, including in vascular ECs11,12. Cx43 hemichannels are primarily closed under physiological conditions13,14; however, they are reported to open upon various, mostly pathological stimuli such as ischemic or inflammatory conditions15,16. Given the large conductance of Cx43 hemichannels, excessive opening of these channels is expected to have deleterious consequences for the integrity of the cell due to dissipative electrical current flow, disturbed cellular ion homeostasis, Ca2+-entry and loss of crucial metabolites such as e.g. ATP or glutamate17,18.
Our aim was to investigate whether selectively targeting Cx43 hemichannels could rescue animals from TNF-induced SIRS, particularly from vascular leakage. We targeted Cx43 hemichannels in vivo by making use of TAT-Gap1919 and TAT-CT920,21,22, respectively known to block or promote Cx43 hemichannel opening (for a review, see11,23). Gap19 and CT9 both have their targets inside the cell, at the C-terminal tail and cytoplasmic loop of Cx43, respectively, and are therefore fused to a translocation sequence (TAT) to improve their membrane permeation in vivo. Combined, our in vivo and in vitro approaches demonstrate that Cx43 hemichannels, through TNF-induced Ca2+-increases, lead to renal vascular permeability and animal mortality in SIRS.
Results
Blocking Cx43 hemichannels protects mice against TNF-induced mortality, hypothermia and vascular permeability alterations
The TNF-induced SIRS model was used to induce acute systemic inflammation, hypothermia and eventually death1,4,24,25. To address the role of Cx43 hemichannel opening, we injected TNF intravenously (i.v.) in C57BL/6J mice in the absence or presence of peptides modulating Cx43 hemichannel function. Prophylactic administration of Gap27 (25 mg/kg i.v.), a peptide mimicking a conserved domain on the second extracellular loop of various Cxs and known to first block hemichannels followed by delayed GJC block26, significantly protected 50% of the mice against TNF-induced hypothermia and mortality (Fig. 1a). To more specifically target Cx43 hemichannels, we prophylactically administered TAT-Gap1919 (5 mg/kg i.v.) and obtained significant protection against hypothermia and mortality (Fig. 1b). Injecting TAT-Gap19 30 min after TNF also significantly protected mice against hypothermia, and led to a smaller but significant reduction in mice mortality (17% vs 50% when administered prophylactically) (Supplemental Fig. 1a,b). Since vascular hyperpermeability is a major pathophysiological feature of SIRS3,27, we assessed the integrity of the endothelial barrier. For this, FITC-dextran was administered i.v. 5 hr post-TNF, and was removed from the blood vessels via transcardial perfusion, after which different organs were isolated to assess overall FITC-dextran leakage (Supplemental Fig. 2a). A significant increase in vascular permeability in colon, ileum, lungs and kidneys was detected 6 hr post-TNF injection (Supplemental Fig. 2b). Interestingly, blocking Cx43 hemichannels by TAT-Gap19 (5 mg/kg) impeded the TNF-induced increase in vascular permeability in the kidney (Fig. 1c), suggesting that Cx43 hemichannels open upon TNF injection, and thus contribute to vascular leakage during SIRS.
Stimulating Cx43 hemichannel opening accelerates TNF-induced mortality, hypothermia and vascular permeability increase
To assess whether increased hemichannel opening would worsen lethality and vascular permeability, TAT-CT9 peptide that mimics part of the C-terminal tail of Cx43 and promotes Cx43 hemichannel opening, was used20,22. When mice were challenged with sub-lethal doses of TNF, TAT-CT9 (10 mg/kg i.v.) sensitized mice to TNF, leading to 100% mortality and stronger hypothermia (Fig. 1d) and furthermore significantly increased vascular permeability in the kidney, when compared to vehicle-treated mice (Fig. 1e). Interestingly, when both TAT-Gap19 and TAT-CT9 were combined at equimolar concentrations (10 mg/kg), TAT-Gap19 counteracted the sensitization effect of TAT-CT9, while increasing the TAT-CT9 concentration to 15 mg/kg, combined with 10 mg/kg TAT-Gap19, again increased hypothermia and mortality (Fig. 1d).
TAT-Gap19 protection against renal vascular leakage is not accompanied by a reduction in cytokine and chemokine production, tissue damage, and release of cell death markers
Since excessive Cx43 hemichannel opening may disturb the transmembrane balance of various ions and molecules, we investigated whether open hemichannels may lead to cell death28. To examine this end-point and the overall inflammatory state, the circulating levels of lactate dehydrogenase (LDH), reporting cell lysis, and pro-inflammatory cytokines and chemokines such as IL-6 and CXCL-1 were analysed 6 hr post-TNF. Increased levels of LDH, IL-6 and CXCL-1, as well as of P-selectin, marking EC activation, were observed (Fig. 2a–c). However, TAT-Gap19 (5 mg/kg) had no significant effect on these parameters (Fig. 2a–c). We further examined renal cell death by TUNEL assays, and surprisingly found no significant increase in TUNEL positivity following TNF compared to vehicle, suggesting TNF does not induce cell death in the kidneys 6 hr after TNF (Fig. 2d). Moreover, interfering with hemichannels by TAT-Gap19 or TAT-CT9 did not influence renal cell death levels after TNF (Fig. 2d). These data show that cell death is not the major cause for the increased renal vascular permeability, and that Cx43 hemichannels are not directly acting on the inflammatory and/or cell death cascades.
TNF activates and promotes Cx43 hemichannel opening in a Ca2+-dependent manner
As TAT-Gap19 and TAT-CT9 respectively led to protection and sensitisation against hypothermia, mortality and permeability in vivo, we further analysed the effect of TNF on Cx43 hemichannel function using whole-cell voltage clamp on HeLa cells stably overexpressing Cx4314,19,29 and EA.hy926 human ECs. In HeLa-Cx43 cells, voltage steps to +70 mV provoked unitary currents with a unitary conductance (γ0) of ~220 pS, consistent with the opening of Cx43 hemichannels (Fig. 3a).
Within 40 s after application of 10 ng/ml TNF, the unitary currents doubled in associated membrane charge transfer, Qm, and the number of hemichannel closing events in the tail currents (Fig. 3a–c). Upon TNF washout, unitary currents reverted to baseline within 40 s; control experiments without TNF or with TNF on HeLa-wildtype (WT) cells had no effect (Supplemental Fig. 3a,b). TNF dose-dependently increased unitary currents with a maximum (~4-fold increase) at 100 ng/ml TNF, and a half-maximal effect (EC50) at ~7.31 ng/ml TNF (Hill coefficient = 3) (Fig. 3d,e). Moreover, Gap19 and CT9 (100 µM) respectively blocked or enhanced TNF-potentiated Cx43 hemichannel activity (Fig. 3f,g). TNF is known to provoke changes of intracellular Ca2+ concentration ([Ca2+]i)30,31, that may modulate Cx43 hemichannel opening32. Accordingly, Ca2+-imaging experiments on HeLa-Cx43 cells demonstrated Ca2+-oscillations in response to 100 ng/ml TNF (Supplemental Fig. 3c,d), and the TNF-induced increase in Qm was prevented by the intracellular application of the Ca2+-chelator BAPTA (10 mM) (p < 0.001) (Fig. 3f,g).
We next tested in EA.hy926 ECs whether TNF could induce hemichannel opening by itself without electrical stimulation and whether [Ca2+]i played a role in activation. At normal resting 50 nM [Ca2+]i, unitary currents only appeared at +60 mV but at higher [Ca2+]i (250 or 500 nM), unitary currents additionally appeared at more physiological negative membrane potential (Fig. 4a). Upon increasing [Ca2+]i further to 1 µM, hemichannel activities again decreased to the level observed at 50 nM (Fig. 4a). A plot of unitary current amplitudes at 500 nM [Ca2+]i, as a function of voltage was characterized by a slope conductance of 222 ± 1 pS, supporting Cx43 hemichannel activity (Fig. 4b). Plotting Qm as a function of [Ca2+]i gave a bell-shaped relation with high hemichannel activity at 500 nM [Ca2+]i and low activity at 50 nM and 1 µM for both negative and positive voltages (Fig. 4d). Gap19 abolished hemichannel activity at 500 nM [Ca2+]i and CT9 enhanced low hemichannel activity at 1 µM [Ca2+]i (Fig. 4c,d). Histogram analysis of unitary currents demonstrated a single-channel conductance of ~220 pS for both control and CT9 (Fig. 4c). Collectively, these observations demonstrate [Ca2+]i-controlled Cx43 hemichannel opening20,33. Finally and most importantly, challenging EA.hy926 cells held at −50 mV resting potential with 100 ng/mL TNF triggered unitary currents with a ~220 pS unitary conductance, which were enhanced by CT9, and abolished by Gap19 and BAPTA [Ca2+]i-buffering, demonstrating Ca2+-dependent activation (Fig. 5a–c).
Ca2+ and CaMKII are implicated in TNF-induced renal vascular permeability
Next, we investigated the role of intracellular Ca2+ in TNF-induced SIRS in vivo by [Ca2+]i chelation with ester-loaded BAPTA-AM (2 mM i.v.)34, and found that it did not protect mice against mortality, but significantly ameliorated body temperatures (Fig. 6a,b), and protected against renal vascular leakage (Fig. 6c).
Open Cx43 hemichannels form a release pathway for ATP35, which may subsequently activate autocrine or paracrine signaling via purinergic P2X- and P2Y-receptors36, thereby inducing Ca2+-increases in nearby cells that may provoke a propagation of hemichannel opening37. We thus tested whether P2X-/P2Y-receptor interference with PPADS, a broad-spectrum P2 receptor antagonist conferred protection against TNF-induced SIRS. PPADS (50 mg/kg i.p.) was found to significantly protect against hypothermia, visible after 6 hr and maintained until 24 hr, and against mortality (Supplemental Fig. 4). In a second instance, we assessed the role of CaMKII during TNF-induced SIRS as it is a known modulator of endothelial barrier integrity38. We found that the CaMKII inhibitor KN-93 (10 mg/kg i.v.) decreased TNF-induced renal vascular leakage, suggesting that CaMKII may be implicated in this process (Figs 6d and 7).
Discussion
Our results indicate involvement of Cx43 hemichannels in TNF-induced SIRS pathology. First, TAT-Gap19 significantly protected mice against mortality, hypothermia and renal vascular permeability, while stimulating hemichannel opening with TAT-CT9 exhibited opposite effects and sensitized mice to TNF. Electrophysiological evidence demonstrated a fast stimulatory effect of TNF on Cx43 hemichannel opening, which was linked to [Ca2+]i-dynamics. In vivo, [Ca2+]i-buffering with BAPTA-AM also protected against renal vascular leakage and hypothermia, and we identified ATP and CaMKII as possible intermediate actors in triggering renal vascular leakage. Collectively, these data assign a new role to Cx43 hemichannels in accelerating renal vascular permeability and mortality during TNF-induced SIRS.
Cx43 channels have previously been implicated in vascular permeability alterations based on in vivo observations under inflammatory or ischemic conditions39,40,41 based on work with extracellular loop mimetic peptides, such as Peptide-5, Gap26 or Gap2711. However, these peptides may affect various Cx isotypes distinct from Cx43 which is a prototypic Cx involved in inflammation. Similarly, Zhang et al. reported a relationship between Cx43 and renal permeability in response to cecal-ligation and puncture (CLP), making use of carbenoxolone39, which inhibits both GJCs and hemichannels, but also affects many other targets42,43. Here, we demonstrated a significant impact of selective Cx43 hemichannel blockade via TAT-Gap19 on renal vascular permeability. Other studies linked an increased ex vivo Cx43 expression in rat kidneys upon lipopolysaccharide treatment to a pro-inflammatory effect44, and showed an upregulation of Cx43 in chronic kidney disease, which was associated with increased pro-inflammatory signalling45. However, in these studies, Cx43 hemichannel functionality was not addressed.
Circulating peptides are rapidly cleared from the blood suggesting that the protective effect of TAT-Gap19 on mortality occurring over a time span of several days involves an early and crucial event. Of interest, in a model of mild CLP in Balb/c mice, Gap26 and TAT-Gap19 exhibited opposite effects, with Gap26 being protective and TAT-Gap19 worsening mortality46. However, the TAT-Gap19 doses used were very high (up to 120 mg/kg compared to 5 mg/kg in this study).
TAT-CT9, which enhances hemichannel opening20,21, was used to contrast the TAT-Gap19 effects, and was shown to sensitize the TNF-induced phenotype in vivo. To understand the opposite effects of TAT-Gap19 and TAT-CT9, we investigated the modulating effect of TNF on hemichannel activity through electrophysiological recording and found that TNF rapidly and dose-dependently stimulated Cx43 hemichannel opening, via [Ca2+]i-elevation. These findings demonstrate that Cx43 hemichannel opening is an early event that may crucially affect the outcome, as exemplified by the strong protective effect of a single injection of TAT-Gap19 on long lasting outcome measurements such as mortality.
It is well known that Cx hemichannels are also involved as a pathway for ATP-release35,47, which subsequently induces [Ca2+]i -elevation in neighbouring cells via paracrine purinergic signalling48,49. In fact, hemichannel-linked ATP-release plays a major role in cell-to-cell propagation of Ca2+-waves37, which have been demonstrated to facilitate spread of inflammation along the vascular endothelium. Interestingly, PPADS protected mice against TNF-induced mortality and hypothermia, suggesting that purinergic receptor activation is contributing to TNF-induced pathology. BAPTA-AM on the other hand only protected mice against TNF-induced hypothermia and renal vascular permeability, but could not rescue against mortality, presumably because BAPTA-AM does not only inhibit pathological Ca2+-signalling, but also interferes with normal cell function. As a result, organ function may be disturbed by BAPTA-AM thereby compromising the function of heart, liver, kidney, brain and others, which may tip the mortality balance and obscure the protective potential.
The causal relation between vascular permeability and mortality is still a matter of debate8. However, different strategies for ameliorating microvascular leakage in several mouse models of sepsis were associated with better survival outcome8. Interestingly, these protective effects were not associated with lower inflammatory cytokine levels, as found here and in another study, investigating the role of receptor interacting protein kinase (RIPK) 1-dependent necroptosis in TNF-induced SIRS3. Although the mechanisms by which vascular permeability is induced are still not fully understood, it is conceivable that excessive opening of hemichannels upon TNF-induced changes in [Ca2+]i could lead to detrimental outcomes in cells, via a cellular imbalance of ionic/molecular gradients17,18 and a subsequent osmotic water flow50. Indeed, the contribution of open hemichannels to cell death induction has been debated in various studies28,41,46 and has been reported in retinal ECs under ischemic conditions41. However, in our study, the TNF challenge did not promote renal cell death, as quantified by TUNEL staining, suggesting it was not causative for the observed TNF-induced renal permeability. In contrast, in the liver, TNF-induced endothelial permeability was shown to be induced by RIPK1-dependent necroptosis3. Another pathway underlying permeability can be attributed to Ca2+ and CaMKII function38. CaMKII has been linked to myosine light chain (MLC)- and MLC kinase-phosphorylation51, which are importantly involved in vascular endothelial barrier dysfunction38,39,52,53. Our finding of decreased renal vascular leakage with KN-93 CaMKII inhibition points to involvement of a Ca2+/CaMKII-dependent cascade, which is a central hub in the signalling cascade leading to endothelial barrier leakage38.
These findings emphasize the specific contribution of Cx43 hemichannels in inducing vascular permeability and blocking these channels protects against TNF-induced vascular leakage, hypothermia and eventually mortality. Limitations of the present study are that the peptides used have a short life-time and low in vivo efficacy and that the TNF-induced SIRS mice model has limited relevance for the complex condition of human SIRS/sepsis. As a result, further studies are needed to unravel the potential role of Cx43 targeted therapies in the clinical setting of SIRS treatment.
Materials and Methods
Cells
HeLa cells, stably transfected with Cx4319,29,54, were cultured in Dulbecco’s modified eagle medium (Invitrogen, Ghent, Belgium), supplemented with 10% fetal bovine serum, 1% sodium pyruvate, 2 mM glutamine, 10 µg/ml streptomycin, 10 U/ml penicillin, 0.25 µg/ml fungizone (Invitrogen, Ghent, Belgium) and 1 µg/ml puromycin (Sigma-Aldrich, Bornem, Belgium). HeLa-WT cells were grown in the medium without puromycin. Mouse GJA1 gene was cloned into the EcoRI/BamHI restricted cloning site of the expression vector pMJgreen. Cytomegalovirus promoter was used. The vector also contains a puromycin N-acetyl-transferase (Pac) gene encoding region. EA.hy926 human ECs, a hybrid clone generated by fusing HUVECs with A549 cells, were cultured in DMEM, supplemented with 10% FBS, 1% L-glutamine, 0.4% sodium pyruvate and 2% HT-supplement (Invitrogen, Ghent, Belgium). All cells were cultured at 37 °C in a 10% CO2 atmosphere and were tested for mycoplasma on a regular basis.
Reagents and antibodies
Recombinant mouse TNF and human TNF were produced in Escherichia coli and purified (>95%) in the VIB Protein Core (IRC, Ghent, Belgium). The biological activity of murine TNF (in vivo) and human TNF (in vitro) was 7.94 × 109 IU/mg and 6.8 × 107 IU/mg respectively, and was determined using an MTT [3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide] assay. Peptides (purity > 95%) were purchased from Pepnome (China) and Genosphere Biotechnologies (Paris, France). Endotoxin contamination was checked by a Limulus Amebocyte Lysate assay and was <1.0 EU/mg. Gap27 (SRPTEKTIFII), TAT-Gap19 (YGRKKRRQRRR-KQIEIKKFK), Gap19 (KQIEIKKFK), TAT-CT9 (YGRKKRRQRRR-RPRPDDLEI), CT9 (RPRPDDLEI) and TAT (YGRKKRRQRRR) were diluted in endotoxin-free phosphate-buffered saline (PBS) or pipette solution for in vivo or in vitro use respectively. BAPTA was purchased from Invitrogen (B1212). BAPTA-AM (Invitrogen, B6769) was dissolved in dimethylsulfoxide (DMSO) (+0.01% pluronic® (Invitrogen)) and further diluted in endotoxin-free PBS for in vivo use. Pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS, Sigma-Aldrich), and KN-93 (Calbiochem) were dissolved in DMSO and further diluted in endotoxin-free PBS for in vivo use. Fluorescein isothiocyanate (FITC)-dextran (4kDa; Sigma-Aldrich) was used in vascular permeability studies.
Electrophysiological recording
Subconfluent cultures of HeLa-Cx43 cells and EA.hy926 cells were seeded on 13-mm-diameter glass coverslips (Knittel Glaser, Novolab, Geraardsbergen, Belgium) and experiments were performed at subconfluency the next day. All recordings were performed in the presence of extracellular Ca2+ and Mg2+ and under conditions of K+-channel blockade with Cs+, Ba2+ and TEA+. Cells were bathed in a recording chamber filled with a modified Krebs-Ringer solution, consisting of (in mM): 150 NaCl, 6 CsCl, 2 MgCl2, 2 CaCl2, 5 glucose (10 for EA.hy926 cells), 5 HEPES, 1 BaCl2 and 2 Pyruvate, with pH adjusted to 7.4. The standard whole-cell recording pipette solution was composed of (in mM): 130 CsCl, 10 NaAsp, 0.26 CaCl2, 5 HEPES, 2 EGTA, 5 TEA-Cl and 1 MgCl2, with pH adjusted to 7.2. For experiments on EA.hy926 cells, 5 mM MgATP was additionally added to the pipette solution. A baseline free intracellular Ca2+ ([Ca2+]i, applied through the whole cell recording pipette) of 50 nM, as well as other concentrations (250, 500 and 1000 nM), were calculated with Webmax Standard software (http://www.stanford.edu/~cpatton/webmaxcS.htm). In experiments where cells were challenged with TNF, the pipette EGTA concentration was 2 mM for HeLa-Cx43 cells and 0.1 mM for EA.hy926 cells; for Ca2+ chelation experiments aimed at suppressing [Ca2+]i changes, EGTA was changed to 10 mM BAPTA. Gap19 and CT9 peptides (100 µM) were added to the pipette solution. Cells were exposed to recombinant human TNF via a fast local perfusion system. An EPC 7 PLUS patch-clamp amplifier (HEKA Elektronik, Lambrecht, Pfalz, Germany) was used for single channel recordings. Data were acquired at 6 kHz using a NI USB-6221 data acquisition device from National Instruments (Austin, TX, USA) and WinWCP acquisition software (designed by Dr. J. Dempster; University of Strathclyde, UK). All currents in whole-cell configuration were filtered at 1 kHz (7-pole Besselfilter). For single channel analysis, holding currents were subtracted from the recorded current traces, giving traces that only contained unitary current events. Unitary conductances were calculated from the elementary current transitions Δi as: γ = Δi/Vm. From these data, we constructed all-point conductance histograms that displayed one or more Gaussian distributions. These were fit by a probability density function assuming independent channel opening19,29,55,56. Channel activity was quantified from the charge transfer Qm associated with unitary currents; this was done by integrating the unitary current traces over the duration of the voltage step as: Qm = ∫idt. Unitary events in the tail currents were counted manually.
Ca2+ imaging
HeLa-Cx43 cells were seeded onto 18-mm-diameter glass coverslips (Knittel Glaser, Novolab, Geraardsbergen, Belgium), and experiments were performed at subconfluency the next day. The cells were loaded with 5 µM fluo3-AM in HBSS-HEPES (1 mM CaCl2, 0.81 mM MgSO4, 13 mM NaCl, 0.18 mM Na2HPO4, 5.36 mM KCl, 0.44 mM KH2PO4, 5.55 mM d-glucose, and 25 mM HEPES) for 45 min at 37 °C. After 45 min, coverslips were washed and then left for an additional 15 min at 37 °C in HBSS-HEPES to allow for de-esterification. Cells were thereafter transferred to an inverted epifluorescence microscope (Eclipse TE 300, Nikon Belux, Brussels, Belgium) equipped with a superfusion system allowing fast solution changes. Superfusion was switched off during the registration of oscillatory activity. Images were taken every second with a 40x oil-immersion objective and an electron-multiplying CCD camera (Quantem 512SC, Photometrics, Tucson, AZ). We used a Lambda DG-4 filterswitch (Sutter Instrument Company, Novato, CA) to deliver excitation at 482 nm and captured emitted light via a 505-nm long-pass dichroic mirror and a 535-nm bandpass filter (35-nm bandwidth). Recordings and analysis were done with custom-developed QuantEMframes and Fluoframes software written in Microsoft Visual C++ 6.0. Oscillatory activity was recorded in a 10 min observation window.
Mice
All mice were bred in specific pathogen-free or in conventional animal facilities, and were males between 8–12 weeks during all the experiments. As connexin expression levels can be altered by the hormonal cycle, male mice were used to limit variability related to the hormonal status. Mice were housed in air-conditioned, temperature-controlled rooms with 14/10-hour light/dark cycles. Food and water were provided ad libitum. C57BL/6J WT mice were purchased from Janvier (Le Genest, France). All mice experiments were organized in accordance with institutional, national, and European animal regulations, and got approved by the animal ethics committee at Ghent University (ECD 2013–064).
TNF induced Lethal Shock – Monitoring and Sampling
Peptides were diluted in endotoxin-free PBS (Sigma-Aldrich) and injected i.v. in a volume of 200 µl at 5 or 10 mg/kg for TAT-Gap19, 5 or 10 mg/kg for TAT, 10 or 15 mg/kg for TAT-CT9, and 25 mg/kg for Gap27, 15 min before i.v. injection of murine TNF (7.5–15 µg/20 g) in 200 µl endotoxin-free PBS (pH 6.8) (prophylactic administration). Therapeutic administration consisted of i.v. injection of 5 mg/kg of TAT-Gap19 30 min after TNF. BAPTA-AM (2 mM in DPBS (6% DMSO)) and KN-93 (10 mg/kg in DPBS (6% DMSO)) were injected i.v. respectively 30 min and 60 min before TNF injection. Control injections consisted of an equal amount (i.v.) of DPBS (6% DMSO). PPADS (50 mg/kg) was injected intraperitoneally (i.p.) 15 min before injection of TNF. Survival and body temperatures were monitored until 5 days post TNF-injection. Rectal body temperatures were recorded with an electric thermometer (Model 1; Comark Electronics, Norwich, UK), and dead mice (25 °C) are included in all body temperature graphs, as was previously implemented1,57. Blood and tissue samples were collected at different time points after injection as outlined in the results section. Blood was collected by cardiac or retro-orbital puncture. Vascular permeability was evaluated as previously described58.
Immunostaining
Tissue was fixed with 4% paraformaldehyde, embedded in paraffin, sectioned at 5 µm and dewaxed before staining procedure was initiated. Cell death was identified by terminal deoxynucleotidyl-transferase dUTP nick-end labeling (TUNEL) staining (TMR in situ cell death detection kit; Roche) in accordance with the manufacturer’s instructions, 6 hr after TNF injection. Sections were counterstained with Hoechst (Sigma-Aldrich). Micrographs were acquired using a Zeiss Axioscan Z.1 slide scanner (Carl Zeiss, Jenna, Germany) at 20x magnification, with a Hamamatsu ORCA Flash4 camera (Hamamatsu Photonics), and illuminated with an HXP 120V light source. Analysis was performed using VolocityⓇ (PerkinElmer, UK) and QuPath (GitHub) softwares.
Determination of LDH, Cytokines and P-selectin
Levels of LDH were measured by an automated clinical analyzer in the University Hospital of Ghent. Cytokine levels of IL-6 and chemokine (C-X-C motif) ligand 1 (CXCL-1) were determined with Luminex magnetic bead-based assays (R&D Systems, Biotechne). Plasma P-selectin levels were measured through a Quantikine ELISA kit (R&D Systems, Biotechne).
Statistics
Statistical analysis was performed in GraphPad Prism (v.7.0). All Kaplan-Meier survival curves were analysed by the log-rank Mantel-Cox test. Body temperatures and vascular permeability assays were analysed by a two-way ANOVA with Tukey’s multiple comparisons test to compare more than two groups, and by a two-way ANOVA with Sidak’s multiple comparisons test to compare two groups. A Shapiro-Wilk normality test indicated normally distributed data. All immunohistochemical and serum parameters were compared with a one-way ANOVA with a Bonferroni post-test to compare all pairs. In the electrophysiology recordings, comparisons between two groups were done with a two-tailed t-test and comparison of more than two groups was performed with a one-way ANOVA and Bonferroni post-hoc test. Significant results are indicated with *for p < 0.05; **for p < 0.01; ***for p < 0.001 or ****for p < 0.0001.
Data availability
All data generated or analysed during this study are included in this published article (and its Supplementary Information Files).
References
Duprez, L. et al. RIP kinase-dependent necrosis drives lethal systemic inflammatory response syndrome. Immunity 35, 908–918 (2011).
Tracey, K. J. et al. Shock and tissue injury induced by recombinant human cachectin. Science 234, 470–474 (1986).
Zelic, M. et al. RIP kinase 1-dependent endothelial necroptosis underlies systemic inflammatory response syndrome. J Clin Invest 128, 2064–2075, https://doi.org/10.1172/JCI96147 (2018).
Newton, K. et al. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury. Cell Death Differ 23, 1565–1576 (2016).
Goddard, L. M. & Iruela-Arispe, M. L. Cellular and molecular regulation of vascular permeability. Thromb Haemost 109, 407–415 (2013).
Clark, P. R., Kim, R. K., Pober, J. S. & Kluger, M. S. Tumor necrosis factor disrupts claudin-5 endothelial tight junction barriers in two distinct NF-kappaB-dependent phases. PLoS One 10, e0120075, https://doi.org/10.1371/journal.pone.0120075 (2015).
Kandasamy, K., Escue, R., Manna, J., Adebiyi, A. & Parthasarathi, K. Changes in endothelial connexin 43 expression inversely correlate with microvessel permeability and VE-cadherin expression in endotoxin-challenged lungs. Am J Physiol Lung Cell Mol Physiol 309, L584–592 (2015).
Goldenberg, N. M., Steinberg, B. E., Slutsky, A. S. & Lee, W. L. Broken barriers: a new take on sepsis pathogenesis. Sci Transl Med 3, 88ps25, https://doi.org/10.1126/scitranslmed.3002011 (2011).
Decrock, E. et al. Connexin-related signaling in cell death: to live or let die? Cell Death Differ 16, 524–536 (2009).
Wang, N. et al. Paracrine signaling through plasma membrane hemichannels. Biochim Biophys Acta 1828, 35–50 (2013).
Delvaeye, T., Vandenabeele, P., Bultynck, G., Leybaert, L. & Krysko, D. Therapeutic targeting of connexin channels: new views and challenges. Trends Mol Med 24, 1036–1053 (2018).
Laird, D. W. Life cycle of connexins in health and disease. Biochem J 394, 527–543 (2006).
Trexler, E. B., Bennet, M. V. L., Bargiello, T. A. & Verselis, V. K. Voltage gating and permeation in a gap junction hemichannel. Proc Natl Acad Sci USA 93, 5836–5841 (1996).
Contreras, J. E., Saez, J. C., Bukauskas, F. F. & Bennett, M. V. Gating and regulation of connexin 43 (Cx43) hemichannels. Proc Natl Acad Sci USA 100, 11388–11393 (2003).
Retamal, M. A. et al. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci 27, 13781–13792 (2007).
De Vuyst, E. et al. Connexin hemichannels and gap junction channels are differentially influenced by Lipopolysaccharide and Basic Fibroblast Growth Factor. Mol Biol Cell 18, 34–46 (2007).
Saez, J. C. et al. Cell membrane permeabilization via connexin hemichannels in living and dying cells. Exp Cell Res 316, 2377–2389 (2010).
Retamal, M. A. et al. Diseases associated with leaky hemichannels. Front Cell Neurosci 9, 267, https://doi.org/10.3389/fncel.2015.00267 (2015).
Wang, N. et al. Selective inhibition of Cx43 hemichannels by Gap19 and its impact on ischemia/reperfusion injury. Basic Res Cardiol 108, 309, https://doi.org/10.1007/s00395-012-0309-x (2013).
Bol, M. et al. At the cross-point of connexins, calcium, and ATP: blocking hemichannels inhibits vasoconstriction of rat small mesenteric arteries. Cardiovasc Res 113, 195–206 (2017).
Retamal, M. A. et al. Opening of pannexin- and connexin-based channels increases the excitability of nodose ganglion sensory neurons. Front Cell Neurosci 8, 158, https://doi.org/10.3389/fncel.2014.00158 (2014).
Ponsaerts, R. et al. Intramolecular loop/tail interactions are essential for connexin 43-hemichannel activity. FASEB J 24, 4378–4395 (2010).
Leybaert, L. et al. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications. Pharmacol Rev 69, 396–478 (2017).
Vanden Berghe, T. et al. Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am J Respir Crit Care Med 189, 282–291 (2014).
Delvaeye, T. et al. Noninvasive whole-body imaging of phosphatidylethanolamine as a cell death marker using (99m)Tc-duramycin during TNF-induced SIRS. J Nucl Med 59, 1140–1145 (2018).
Wang, N. et al. Connexin targeting peptides as inhibitors of voltage- and intracellular Ca2+-triggered Cx43 hemichannel opening. Neuropharmacology 75, 506–516 (2013).
Vandendriessche, B. et al. MAPK-activated protein kinase 2-deficiency causes hyperacute tumor necrosis factor-induced inflammatory shock. BMC Physiol 14, 5, https://doi.org/10.1186/s12899-014-0005-1 (2014).
Decrock, E. et al. Connexin 43 hemichannels contribute to the propagation of apoptotic cell death in a rat C6 glioma cell model. Cell Death Differ 16, 151–163 (2009).
Wang, N. et al. Connexin mimetic peptides inhibit Cx43 hemichannel opening triggered by voltage and intracellular Ca2+ elevation. Basic Res Cardiol 107, 304, https://doi.org/10.1007/s00395-012-0304-2 (2012).
Duncan, D. J., Yang, Z., Hopkins, P. M., Steele, D. S. & Harrison, S. M. TNF-alpha and IL-1beta increase Ca2+ leak from the sarcoplasmic reticulum and susceptibility to arrhythmia in rat ventricular myocytes. Cell Calcium 47, 378–386 (2010).
De, A., Krueger, J. M. & Simasko, S. M. Tumor necrosis factor α increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons. Brain Res 981, 133–142 (2003).
De Vuyst, E. et al. Ca(2+) regulation of connexin 43 hemichannels in C6 glioma and glial cells. Cell Calcium 46, 176–187 (2009).
De Bock, M. et al. Connexin 43 hemichannels contribute to cytoplasmic Ca2+ oscillations by providing a bimodal Ca2+-dependent Ca2+ entry pathway. J Biol Chem 287, 12250–12266 (2012).
Tsien, R. Y. A non-disruptive technique for loading calcium biffers and indicators into cells. Nature 290, 527–528 (1981).
Kang, J. et al. Connexin 43 hemichannels are permeable to ATP. J Neurosci 28, 4702–4711 (2008).
Albert, J. L. et al. Regulation of brain capillary endothelial cells by P2Y receptors coupled to Ca2+, phospholipase C and mitogen-activated protein kinase. Br J Pharmacol 122, 935–941 (1997).
Leybaert, L. & Sanderson, M. J. Intercellular Ca(2+) waves: mechanisms and function. Physiol Rev 92, 1359–1392 (2012).
Borbiev, T., Verin, A. D., Shi, S., Liu, F. & Garcia, J. G. N. Regulation of endothelial cell barrier function by calcium/calmodulin-dependent protein kinase II. Am J Physiol Lung Cell Mol Physiol 280, 983–990 (2001).
Zhang, J. et al. Role of connexin 43 in vascular hyperpermeability and relationship to Rock1-MLC20 pathway in septic rats. Am J Physiol Lung Cell Mol Physiol 309, L1323–1332 (2015).
Parthasarathi, K. Endothelial connexin43 mediates acid-induced increases in pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol 303, L33–42 (2012).
Danesh-Meyer, H. V. et al. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia. Brain 135, 506–520 (2012).
Vessey, J. P. et al. Carbenoxolone inhibition of voltage-gated Ca channels and synaptic transmission in the retina. J Neurophysiol 92, 1252–1256 (2004).
Lohman, A. W. et al. Pannexin 1 channels regulate leukocyte emigration through the venous endothelium during acute inflammation. Nat Commun 6, 7965, https://doi.org/10.1038/ncomms8965 (2015).
Fernandez-Cobo, M., Gingalewski, C. & De Maio, A. Expression of the connexin 43 gene is increased in the kidneys and the lungs of rats injected with bacterial lipopolysaccharide. Shock 10, 97–102 (1998).
Toubas, J. et al. Alteration of connexin expression is an early signal for chronic kidney disease. Am J Physiol Renal Physiol 301, F24–32 (2011).
Li, W. et al. Connexin 43 Hemichannel as a Novel Mediator of Sterile and Infectious Inflammatory Diseases. Sci Rep 8, 166, https://doi.org/10.1038/s41598-017-18452-1 (2018).
Lohman, A. W., Billaud, M. & Isakson, B. E. Mechanisms of ATP release and signalling in the blood vessel wall. Cardiovasc Res 95, 269–280 (2012).
Stout, C. E., Costantin, J. L., Naus, C. C. & Charles, A. C. Intercellular calcium signaling in astrocytes via ATP release through connexin hemichannels. J Biol Chem 277, 10482–10488 (2002).
Pubill, D. et al. ATP induces intracellular calcium increases and actin cytoskeleton disaggregation via P2x receptors. Cell Calcium 29, 299–309 (2001).
Rodriguez-Sinovas, A. et al. The modulatory effects of connexin 43 on cell death/survival beyond cell coupling. Prog Biophys Mol Biol 94, 219–232 (2007).
Garcia, J. G. N., Davis, H. W. & Patterson, C. E. Regulation of endothelial cell gap formation and barrier dysfunction: role of myosin light chain phosphorylation. J Cell Physiol 163, 510–522 (1995).
McKenzie, J. A. & Ridley, A. J. Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability. J Cell Physiol 213, 221–228 (2007).
O’Donnell, J. J. 3rd, Birukova, A. A., Beyer, E. C. & Birukov, K. G. Gap junction protein connexin43 exacerbates lung vascular permeability. PLoS One 9, e100931, https://doi.org/10.1371/journal.pone.0100931 (2014).
Elfgang, C. et al. Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol 129, 805–817 (1995).
Ramanan, S. V. & Brink, P. R. Multichannel recordings from membranes which contain gap junctions. Biophys J 65, 1387–1395 (1993).
Wang, H. et al. Intercellular communication in cultured human vascular smooth muscle cells. Am J Physiol Cell Physiol 281, 75–88 (2001).
Cauwels, A. et al. Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase-dependent manner. J Exp Med 206, 2915–2924 (2009).
Vandenbroucke, R. E. et al. Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases. J Neurosci 32, 9805–9816 (2012).
Acknowledgements
We would like to thank Tatyana Divert and Elien Van Wonterghem for their technical assistance. We would also like to thank the VIB Bioimaging Core for training, support and access to the instrument park. Research in the LL group is supported by the Fund for Scientific Research Flanders, Belgium (grant G.0A82.13N and G.0527.18N), the Interuniversity Attraction Poles Program (grant P7/10), Ghent University (Special Research Fund (BOF)) and the Geneeskundige Stichting Koningin Elisabeth (grant STI.DI2.2017.0004.01). M.D.S. is supported by a personal grant from the Fund for Scientific Research Flanders (1124418N). Research in the D.V.K. group is supported by Fund for Scientific Research Flanders (1506218N, 1507118N, G051918N and G039619N) and Ghent University (Special Research Fund, BOF 14-GOA-019 and IOP 01/O3618). Research in the PV group is supported by Flemish grants (EOS MODEL-IDI consortium, G.0C31.14N, G.0C37.14N, G.0E04.16N, G.0C76.18N, and G.0B71.18N), Methusalem (BOF16/MET_V/007), ‘Foundation against Cancer’ (FAF-F/2016/865) and grants from VIB. T.D. was paid by FWO G.0A54.13N to D.V.K. and L.L. and the Methusalem grants to P.V.
Author information
Authors and Affiliations
Contributions
T.D. wrote the manuscript, and designed and conducted most of the experiments. M.D.S. and L.L. designed electrophysiological experiments, M.D.S. and S.V. performed electrophysiological experiments and analysis. M.D.S. and T.D. constructed electrophysiology figures and wrote the electrophysiological part of the manuscript. E.D. helped with the design of the experiments, gave scientific input and revised the manuscript. R.E.V. and A.C. assisted during the vascular permeability assay, and R.E.V. designed the assay. K.L. performed immunohistochemical staining and A.G. assisted in immunohistochemical imaging. W.D. gave scientific input and revised the manuscript. P.V., D.V.K. and L.L. initiated, designed and supervised the project, gave scientific input and revised the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Delvaeye, T., De Smet, M.A.J., Verwaerde, S. et al. Blocking connexin43 hemichannels protects mice against tumour necrosis factor-induced inflammatory shock. Sci Rep 9, 16623 (2019). https://doi.org/10.1038/s41598-019-52900-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-019-52900-4
- Springer Nature Limited
This article is cited by
-
Immunomodulatory and clinical effects of receptor-interacting protein kinase 1 (RIPK1) inhibitor eclitasertib (SAR443122) in patients with severe COVID-19: a phase 1b, randomized, double-blinded, placebo-controlled study
Respiratory Research (2024)
-
Opening of Cx43-formed hemichannels mediates the Ca2+ signaling associated with endothelial cell migration
Biology Direct (2023)